Brief: MEI Pharma Announces Departure Of CEO Daniel Gold And Appointment Of David Urso As Successor
02/06/2023 14:08
June 2 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA ANNOUNCES PLANNED DEPARTURE OF CEO DANIEL P.
GOLD,
PH.D. AND APPOINTMENT OF DAVID M. URSO AS SUCCESSOR
* MEI PHARMA INC SAYS GOLD'S TENURE AS PRESIDENT AND CHIEF
EXECUTIVE OFFICER OF MEI WILL END ON JUNE 2, 2023
Source text for Eikon: ID:nBwBKtkma
Further company coverage: MEIP.O
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations